TABLE 5.
Covariate | Unadjusted | Adjusteda |
---|---|---|
OR (95% CI) (LB–UB) | OR (95% CI) (LB–UB) | |
Age 1-yr increase from 65 yr | 0.97 (0.94–0.99) | 0.96 (0.93–0.99) |
Body mass index ≥30 vs <30 | 0.85 (0.44–1.64) | 1.76 (0.61–5.07) |
P/F >200 vs <100 | 6.25 (2.23–17.54) | 6.70 (1.56–28.84) |
P/F category 100–200 vs <100 | 3.70 (1.60–8.57) | 6.57 (2.03–21.33) |
pH ≥7.30 vs <7.30 | 0.99 (0.49–1.98) | 0.83 (0.22–3.08) |
Paco2 ≥70 vs <70 | 0.73 (0.38–1.39) | 0.76 (0.24–2.38) |
Diagnosis COVID-19 vs ARDS | 0.41 (0.21–0.82) | 0.26 (0.08–0.81) |
Diagnosis other vs ARDS | 0.47 (0.08–2.75) | 0.40 (0.05–3.09) |
Diagnosis asthmaticus vs ARDS | 5.60 (0.63–49.45) | 2.06 (0.19–22.97) |
Diagnosis COVID-19 vs other | 0.89 (0.15–5.13) | 0.64 (0.08–5.14) |
Diagnosis COVID-19 vs asthmaticus | 0.07 (0.01–0.64) | 0.12 (0.01–1.47) |
Diagnosis other vs asthmaticus | 0.08 (0.01–1.26) | 0.19 (0.01–3.73) |
Anticoagulation target recommended vs not recommended | 2.22 (1.07–4.60) | 2.37 (0.91–6.09) |
ARDS = acute respiratory distress syndrome, OR = odds ratio, LB = lower bound, P/F = Pao2:Fio2, UB = upper bound.
Adjusted for age (as a continuous variable), body mass index (dichotomized), diagnosis, anticoagulation target, baseline pH, and Paco2.
Boldface values indicate statistical significance.